Treatment of opportunistic infections

J. P. Phair*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


An expanding armamentarium of therapeutic and prophylactic agents presents several clinical and research challenges, such as determining who requires which prophylaxes and when. In the absence of a single 'gorillamycin', patients' quality of life will depend upon our ability to make multidrug regimens safe, palatable, and manageable.

Original languageEnglish (US)
Pages (from-to)27-36
Number of pages10
JournalInfections in Medicine
Issue numberSUPPL. F
StatePublished - 1992

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Treatment of opportunistic infections'. Together they form a unique fingerprint.

Cite this